The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 03, 2023
Filed:
Feb. 02, 2017
Applicant:
Celgene Car Llc, Pembroke, BM;
Inventors:
Russell C. Petter, Stow, MA (US);
Charles F. Jewell, Columbia, MD (US);
Kwangho Lee, Waltham, MA (US);
Aravind Prasad Medikonda, Arlington, MA (US);
Deqiang Niu, Lexington, MA (US);
Lixin Qiao, Andover, MA (US);
Juswinder Singh, Ashland, MA (US);
Zhendong Zhu, Westborough, MA (US);
Assignee:
Celgene CAR LLC, Pembroke, BM;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/96 (2006.01); G16B 15/00 (2019.01); C07D 405/14 (2006.01); C07D 491/08 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); G01N 33/68 (2006.01); C07D 519/00 (2006.01); C07D 401/04 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 417/14 (2006.01); C07D 207/16 (2006.01); C07D 417/06 (2006.01); C07D 493/04 (2006.01); C07D 409/12 (2006.01); C07D 401/14 (2006.01); C07D 239/49 (2006.01); C07D 513/04 (2006.01); G16C 20/50 (2019.01); G16B 15/30 (2019.01); C07D 403/14 (2006.01); C12N 9/12 (2006.01); C12N 9/50 (2006.01); C12N 9/00 (2006.01); C12Q 1/25 (2006.01); C12Q 1/37 (2006.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
C12N 9/96 (2013.01); C07D 207/16 (2013.01); C07D 239/49 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 417/06 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01); C07D 491/08 (2013.01); C07D 493/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01); C12N 9/12 (2013.01); C12N 9/506 (2013.01); C12N 9/93 (2013.01); C12Q 1/25 (2013.01); C12Q 1/37 (2013.01); C12Q 1/485 (2013.01); C12Y 207/11001 (2013.01); C12Y 304/21098 (2013.01); C12Y 603/02 (2013.01); G01N 33/68 (2013.01); G16B 15/00 (2019.02); G16B 15/30 (2019.02); G16C 20/50 (2019.02);
Abstract
The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.